蜡油样骨病的诊疗现状  

Diagnosis and treatment status quo of melorheostosis

作　　者：张志伟[1] 沈为栋[1] 

机构地区：[1]中南大学湘雅医学院第八临床学院骨科研究所,湖南岳阳414000

出　　处：《中华临床医师杂志（电子版）》2015年第3期118-122,共5页Chinese Journal of Clinicians(Electronic Edition)

摘　　要：蜡油样骨病(melorheostosis)是一种罕见的、病因不明的良性骨质增生硬化性疾病。1922年Leri和Joanny首次报道,国外统计发病率约为0.9/100万[2]。本病国内外少有报道,随着X线等检查不断发展与普及,报道逐渐增多,特此就本病的诊疗现状作一综述,以期为临床诊疗提供一定帮助。Melorheostosis is a rare, benign bone hyperplasia sclerosing disease of unknown etiology. Left and Joanny first reported in 1922, the foreign statistical incidence of about 0.9 parts per million. This disease was rare reported at home and abroad. With the development and popularization, the examination such as X-ray, reports of the disease gradually increased. In this paper, we reviewed the current diagnosis and treatment of the disease, in order to provide certain help for clinical diagnosis and treatment.

关 键 词：诊断 治疗 蜡油样骨病 

分 类 号：R681[医药卫生—骨科学]